glp-1 cardiovascular outcome trials SGLTi and in HF Summary of cardiovascular outcome trials

At 5 mg/mL, the entire dose range from 0.25 mg through 2.4 mg fits comfortably within a 50-unit syringe

Your smaller body simply burns fewer calories at rest than it did at a higher weight

Theyre vanity drugs. In reality, theyre tools for treating obesity, type 2 diabetes, and even reducing risks of cardiovascular and kidney disease

Some individuals require a slightly higher or lower dose as their body adapts to weight loss

Over the course of a year, the difference between brand name list price and a compounded alternative can exceed $7,000 to $10,000

Safe and effective use of the once weekly dulaglutide single-dose pen in injection-naive patients with type 2 diabetes